All Insights White Paper Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?
Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?
Updated in March 2020
![Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?](https://insights.axtria.com/hubfs/Axtria-2023/solutions/WP-Impact-Of-COVID-19-Cover.jpg)
Events surrounding the coronavirus contagion, characterized as a “black swan” event, which started in China, remain very fluid and are changing daily. No one really knows what the future holds and what if any long-term global effects may result from this latest contagion. Therefore, this paper is about expanding on two themes that are of importance to the successful long-term operation of global pharmaceutical companies:
- What are the possible economic effects of this contagion on the global pharmaceutical industry that we can surmise at this time? This paper will outline in a structurally logical fashion the demand-side and supply-side pharma industry effects. The depth and extent of the effects of the coronavirus will depend on its geographic reach and length of time of existence.
- The other key related theme is that the coronavirus illustrates that pharma companies, as complex global organizations, are subject to numerous risks and uncertainties. This requires a pharma company to have a sophisticated culture of analytics to mitigate the effects when these surprise events occur.
Contact us at insights@axtria.com with any questions.
Complete the brief form to download the white paper
Recommended insights
![Economic Impact of the Coronavirus on the Pharma Industry](https://insights.axtria.com/hubfs/Revolutionizing%20Information%20Access%20and%20Decision-Making%20With%20Generative%20AI.jpg)
Case Study
Revolutionizing Information Access and Decision-Making With Generative AI for a Top 5 Pharma
![Economic Impact of the Coronavirus on the Pharma Industry](https://insights.axtria.com/hubfs/Five%20Pillars%20of%20Implementation%20for%20Pharma%20Sales%20Force%20Effectiveness.jpg)
Report